Literature DB >> 25761709

The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study.

Valentina Marziano1, Piero Poletti2, Giorgio Guzzetta3, Marco Ajelli4, Piero Manfredi5, Stefano Merler6.   

Abstract

Varicella zoster virus (VZV) causes varicella upon first exposure and may reactivate later in life into herpes zoster (HZ), with a risk that is thought to be reduced by re-exposures to VZV. Given the decades-long time scales of reactivation and its dependence on the accumulation of re-exposure episodes, adopting a long-term perspective may be useful to correctly interpret current epidemiological trends of VZV. In this study, we investigate the possible impact of demographic changes on varicella and HZ in Spain, using an age-structured mathematical model informed with historical demographic data and calibrated against age-specific profiles of varicella seroprevalence and HZ incidence data. The model qualitatively reproduces the remarkable growth of HZ incidence observed in Spain between 1997 and 2004, before the introduction of varicella vaccination programmes. We demonstrate that this growth may be partially ascribed to the reduction of varicella circulation that followed the overall decline of the birth rate in the twentieth century. Model predictions further suggest that, even under the most optimistic projections, HZ incidence will continue its rise until at least 2040. Considering the effect of demographic changes can help interpreting variations in epidemiological trends of HZ, contributing to a more accurate evaluation of vaccination programmes against VZV.
© 2015 The Author(s) Published by the Royal Society. All rights reserved.

Entities:  

Keywords:  demographic transition; herpes zoster; mathematical modelling; varicella

Mesh:

Year:  2015        PMID: 25761709      PMCID: PMC4375857          DOI: 10.1098/rspb.2014.2509

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  36 in total

1.  Realistic population dynamics in epidemiological models: the impact of population decline on the dynamics of childhood infectious diseases. Measles in Italy as an example.

Authors:  Piero Manfredi; John R Williams
Journal:  Math Biosci       Date:  2004-12-10       Impact factor: 2.144

2.  Secular trends in the epidemiology of shingles in Alberta.

Authors:  M L Russell; D P Schopflocher; L Svenson; S N Virani
Journal:  Epidemiol Infect       Date:  2007-02-12       Impact factor: 2.451

3.  Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster.

Authors:  Marc Brisson; Gurgen Melkonyan; Melanie Drolet; Gaston De Serres; Roseline Thibeault; Philippe De Wals
Journal:  Vaccine       Date:  2010-03-01       Impact factor: 3.641

4.  Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.

Authors:  Leonardo Emberti Gialloreti; Monica Merito; Patrizio Pezzotti; Luigi Naldi; Antonio Gatti; Maud Beillat; Laurence Serradell; Rafaelle di Marzo; Antonio Volpi
Journal:  BMC Infect Dis       Date:  2010-08-03       Impact factor: 3.090

5.  Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians.

Authors:  Benson Ogunjimi; Evelien Smits; Steven Heynderickx; Johan Van den Bergh; Joke Bilcke; Hilde Jansens; Ronald Malfait; Jose Ramet; Holden T Maecker; Nathalie Cools; Philippe Beutels; Pierre Van Damme
Journal:  Clin Vaccine Immunol       Date:  2014-01-15

6.  The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region.

Authors:  A Nardone; F de Ory; M Carton; D Cohen; P van Damme; I Davidkin; M C Rota; H de Melker; J Mossong; M Slacikova; A Tischer; N Andrews; G Berbers; G Gabutti; N Gay; L Jones; S Jokinen; G Kafatos; M V Martínez de Aragón; F Schneider; Z Smetana; B Vargova; R Vranckx; E Miller
Journal:  Vaccine       Date:  2007-08-08       Impact factor: 3.641

Review 7.  The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.

Authors:  Meredith A Reynolds; Sandra S Chaves; Rafael Harpaz; Adriana S Lopez; Jane F Seward
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

8.  The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003.

Authors:  W Katherine Yih; Daniel R Brooks; Susan M Lett; Aisha O Jumaan; Zi Zhang; Karen M Clements; Jane F Seward
Journal:  BMC Public Health       Date:  2005-06-16       Impact factor: 3.295

9.  Varicella and herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997-2004.

Authors:  Napoleón Pérez-Farinós; María Ordobás; Cristina García-Fernández; Luis García-Comas; Soledad Cañellas; Inmaculada Rodero; Angeles Gutiérrez-Rodríguez; Juan García-Gutiérrez; Rosa Ramírez
Journal:  BMC Infect Dis       Date:  2007-06-15       Impact factor: 3.090

10.  Social contacts and mixing patterns relevant to the spread of infectious diseases.

Authors:  Joël Mossong; Niel Hens; Mark Jit; Philippe Beutels; Kari Auranen; Rafael Mikolajczyk; Marco Massari; Stefania Salmaso; Gianpaolo Scalia Tomba; Jacco Wallinga; Janneke Heijne; Malgorzata Sadkowska-Todys; Magdalena Rosinska; W John Edmunds
Journal:  PLoS Med       Date:  2008-03-25       Impact factor: 11.069

View more
  13 in total

1.  The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling.

Authors:  Giorgio Guzzetta; Piero Poletti; Stefano Merler; Piero Manfredi
Journal:  Am J Epidemiol       Date:  2016-03-18       Impact factor: 4.897

2.  Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.

Authors:  Johannes Horn; André Karch; Oliver Damm; Mirjam E Kretzschmar; Anette Siedler; Bernhard Ultsch; Felix Weidemann; Ole Wichmann; Hartmut Hengel; Wolfgang Greiner; Rafael T Mikolajczyk
Journal:  Hum Vaccin Immunother       Date:  2016-02-02       Impact factor: 3.452

3.  Exploring the Seasonal Drivers of Varicella Zoster Virus Transmission and Reactivation.

Authors:  Kevin M Bakker; Marisa C Eisenberg; Robert Woods; Micaela E Martinez
Journal:  Am J Epidemiol       Date:  2021-09-01       Impact factor: 5.363

4.  Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study.

Authors:  Johannes Horn; Oliver Damm; Wolfgang Greiner; Hartmut Hengel; Mirjam E Kretzschmar; Anette Siedler; Bernhard Ultsch; Felix Weidemann; Ole Wichmann; André Karch; Rafael T Mikolajczyk
Journal:  BMC Med       Date:  2018-01-09       Impact factor: 8.775

5.  The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster.

Authors:  Luigi Marangi; Grazina Mirinaviciute; Elmira Flem; Gianpaolo Scalia Tomba; Giorgio Guzzetta; Birgitte Freiesleben de Blasio; Piero Manfredi
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

6.  Modeling the impact of changes in day-care contact patterns on the dynamics of varicella transmission in France between 1991 and 2015.

Authors:  Valentina Marziano; Piero Poletti; Guillaume Béraud; Pierre-Yves Boëlle; Stefano Merler; Vittoria Colizza
Journal:  PLoS Comput Biol       Date:  2018-08-01       Impact factor: 4.475

7.  Evaluation of the effect of chickenpox vaccination on shingles epidemiology using agent-based modeling.

Authors:  Ellen Rafferty; Wade McDonald; Weicheng Qian; Nathaniel D Osgood; Alexander Doroshenko
Journal:  PeerJ       Date:  2018-06-20       Impact factor: 2.984

8.  Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data.

Authors:  Harriet Forbes; Ian Douglas; Adam Finn; Judith Breuer; Krishnan Bhaskaran; Liam Smeeth; Simon Packer; Sinéad M Langan; Kathryn E Mansfield; Robin Marlow; Heather Whitaker; Charlotte Warren-Gash
Journal:  BMJ       Date:  2020-01-22

9.  The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study.

Authors:  Alessia Melegaro; Valentina Marziano; Emanuele Del Fava; Piero Poletti; Marcello Tirani; Caterina Rizzo; Stefano Merler
Journal:  BMC Med       Date:  2018-07-17       Impact factor: 8.775

10.  The potential impact of the demographic transition in the Senegal-Gambia region of sub-Saharan Africa on the burden of infectious disease and its potential synergies with control programmes: the case of hepatitis B.

Authors:  John R Williams; Piero Manfredi; Alessia Melegaro
Journal:  BMC Med       Date:  2018-07-25       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.